FRI-136-Hepatitis B core antibody (anti-HBc) mirrors activation of hepatitis B virus-specific immune responses and exhibits direct effect on hepatitis B virus control

2019 ◽  
Vol 70 (1) ◽  
pp. e447
Author(s):  
Chengcong Chen ◽  
Yongyin Li ◽  
Ling Guo ◽  
Yang Zhou ◽  
Xuan Yi ◽  
...  
2021 ◽  
Author(s):  
Helena Zábranská ◽  
Aleš Zábranský ◽  
Barbora Lubyová ◽  
Jan Hodek ◽  
Alena Křenková ◽  
...  

Hepatitis B virus (HBV) uses e antigen (HBe), which is dispensable for virus infectivity, to modulate host immune responses and achieve viral persistence in human hepatocytes. The HBe precursor (p25) is directed to the endoplasmic reticulum (ER), where cleavage of the signal peptide (sp) gives rise to the first processing product, p22. P22 can be retro-translocated back to the cytosol or enter the secretory pathway and undergo a second cleavage event, resulting in secreted p17 (HBe). Here, we report that translocation of p25 to the ER is promoted by translocon-associated protein complex (TRAP). We found that p25 is not completely translocated into the ER; a fraction of p25 is phosphorylated and remains in the cytoplasm and nucleus. Within the p25 sp sequence, we identified three cysteine residues that control the efficiency of sp cleavage and contribute to proper subcellular distribution of the precore pool.


1980 ◽  
Vol 30 (3) ◽  
pp. 728-733
Author(s):  
Y Sanchez ◽  
I Ionescu-Matiu ◽  
G R Dreesman ◽  
W Kramp ◽  
H R Six ◽  
...  

Complete Freud adjuvant, aluminum gel, and liposomes were compared for their ability to enhance the immunogenicity of an intact 22-nm HBsAg particle vaccine and an HBsAg-derived polypeptide vaccine in guinea pigs. Both humoral and cell-mediated immune responses were evaluated. The greatest immune response was obtained with complete Freund adjuvant, regardless of the antigen preparation. Aluminum gel appeared to be a better adjuvant for 22-nm HBsAg particles, but the liposomes rendered polypeptide preparations more immunogenic. The possibility that various proportions were entrapped in aqueous compartments instead of being inserted into the lipid bilayers of liposomes might account for this difference. The development of both humoral and cellular immunity was dependent upon the use of an adjuvant, because aqueous preparations had poor immunogenicity.


Vaccine ◽  
2001 ◽  
Vol 20 (1-2) ◽  
pp. 140-147 ◽  
Author(s):  
Bo-jian Zheng ◽  
Patrick C.Y Woo ◽  
Mun-hon Ng ◽  
Hoi-wah Tsoi ◽  
Lei-po Wong ◽  
...  

2014 ◽  
Vol 21 (12) ◽  
pp. 860-872 ◽  
Author(s):  
M. Jiang ◽  
R. Broering ◽  
M. Trippler ◽  
L. Poggenpohl ◽  
M. Fiedler ◽  
...  

2013 ◽  
Vol 5 (2) ◽  
pp. 64-67
Author(s):  
Rajendra Desai ◽  
M. Anuradha ◽  
Yashavanth Kumar ◽  
V Harsha.

ABSTRACT Hepatitis B virus (HBV) infection is a major cause of morbidity and mortality worldwide. Hepatitis B is spread through contact with blood or body fluids of an infected person. Hepatitis B virus (HBV) is the major cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The likelihood of developing Chronic Hepatitis B is related to the age at which infection is acquired; the risk being lowest in adults and >90% in neonates whose mothers are hepatitis B e antigen positive. HBV is not directly cytopathic and liver injury appears to be mostly caused by repeated attempts of the host's immune responses to control the infection. After reviewing the various articles, the following protocols are best suited for the health care workers.


Sign in / Sign up

Export Citation Format

Share Document